AML Contender Quizartinib Gains First Approval, In Japan

 
• By Ian Haydock
  
Acute myeloid leukemia a 3d-Render
Japan Approval For Quizartinib In AML • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Japan

More from Focus On Asia